Results 251 to 260 of about 2,657,421 (309)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Development of ultrasound-visualized tumor-targeting engineered bacteria for precise tumor therapy. [PDF]

Synth Syst Biotechnol
Qu L, Chi Z, Zou ZP, Zhou Y, Ye BC.
europepmc   +1 more source

Tumor-targeting nanocarriers amplified immunotherapy of cold tumors by STING activation and inhibiting immune evasion. [PDF]

Sci Adv
Zhao J, Tong A, Liu J, Xu M, Mi P.
europepmc   +1 more source

Platelet hitchhiking vascular-disrupting agents for self-amplified tumor-targeting therapy. [PDF]

J Nanobiotechnology
Chu H, Xu Y, Shan Y, Sun M, Zhao W, Fang X, Shen N, Tang Z.   +7 more
europepmc   +1 more source

Gold Nanoparticles as Targeted Drug Delivery Systems for Liver Cancer: A Systematic Review of Tumor Targeting Efficiency and Toxicity Profiles. [PDF]

Int J Mol Sci
Cosma M, Mocan T, Delcea C, Pop T, Mosteanu O, Mocan L.   +5 more
europepmc   +1 more source

Albumin Nanocages with Methotrexate and Chondroitin Sulfate as a Dual pH/GSH-Responsive Tumor Targeting Nanomedicine for Synergistic Cancer Therapy. [PDF]

Biomater Res
Iqbal H, Razzaq A, Yuan Z, Zhai L, Wang Y, Ur-Rehman U, Man L, Xin J, Ning X, Liang Y, Xiao R.   +10 more
europepmc   +1 more source

Albumin-conjugation enables improved tumor targeting of aptamers via SPECT imaging. [PDF]

Mol Ther Nucleic Acids
Yang S, Zheng C, Cheng S, Wen L, Li P, Li J, Lan X, Jiang D.   +7 more
europepmc   +1 more source

Founding Editorial: Neuro‐Drug Discovery

Neuro-Drug Discovery, EarlyView.
Wenbin Li
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Targeting the Tumor-Tumor Microenvironment Crosstalk

Expert Opinion on Therapeutic Targets, 2023
Cancer development and progression is a complex process influenced by co-evolution of the cancer cells and their microenvironment. However, traditional anti-cancer therapy is mostly targeted toward cancer cells. To improve the efficacy of cancer drugs, the complex interactions between the tumor (T) and the tumor microenvironment (TME) should be ...
Sunil S. Badve, Yesim Gökmen-Polar
openaire   +2 more sources

Tumor vasculature-targeting nanomedicines

Acta Biomaterialia, 2021
Uncontrolled tumor growth and subsequent distant metastasis are highly dependent on an adequate nutrient supply from tumor blood vessels, which have relatively different pathophysiological characteristics from those of normal vasculature. Obviously, strategies targeting tumor vasculature, such as anti-angiogenic drugs and vascular disrupting agents ...
Ying, Zhang, Jingni, He
openaire   +2 more sources